RETAVIBART
UNII HQ9W597Z73

Substance Identification & Data

This profile provides standardized clinical and technical data for Retavibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HQ9W597Z73.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3023741-03-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HQ9W597Z73

CAS Registry Number

3023741-03-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RETAVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215759

National Cancer Institute reference terminology for clinical and research data.

INN ID

13554

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retavibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RETAVIBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-457) (VH (HOMO SAPIENS IGHV5-51*01 (86.7%) -(IGHD) -IGHJ2*01 (93.8%), CDR-IMGT (8.8.20) (26-33.51-58.97-116)) (1-127) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, 9-G1V24 CH3 L107, S114 (CH1 R120 (224) (128-225), HINGE 1-15 (226-240), CH2 (241-350), CH3 E12 (366), M14 (368), M107>L (438), N114>S (444) (351-455), CHS (456-457)) (128-457)), (230-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (92.6%) -IGKJ5*01 (91.7%) I126>N (107'), CDR-IMGT (6.3.10) (27'-32'.50'-52'.89'-98'))(1'-108') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')); DIMER (236-236'':239-239'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (438-LEUCINE,444-SERINE), ANTI-(RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN) (HUMAN MONOCLONAL TNM001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TNM001 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) FUSION GLYCOPROTEIN F), HOMO SAPIENS MONOCLONAL ANTIBODY (RETAVIBART)

RETAVIBART [INN]